Miami Lakes, Florida Clinical Trials

A listing of Miami Lakes, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 38 clinical trials
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis

This is a phase 1, open label, single arm study in which ARQ-151 cream 0.3% is applied QD for 2 weeks to adolescent subjects with chronic plaque psoriasis involving at least 10% body surface area (BSA) and adult subjects with chronic plaque psoriasis involving at least 20% BSA (excluding scalp). …

psoriasis
electrocardiogram
psoriasis vulgaris
serum pregnancy test
12 lead electrocardiogram
Arcutis Clinical Site 06
 (2.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

heart disease
dyspnea
headache
covid-19
hypertension
I R & Health Center, Inc.
 (3.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +61 other locations
A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)

The purpose of this study to evaluate the efficacy of SAGE-217 in the treatment of participants with MDD.

benzodiazepines
structured clinical interview
antidepressants
psychiatric disorder
depressive disorder
Sage Investigational Site
 (9.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +35 other locations
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants  

Primary Objective: To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection). To assess the immune response (serotype specific IgG concentration) of the SP0202 formulations and Prevnar 13 1 month after the administration of one dose in toddlers (Groups …

Investigational Site Number 8400047
 (6.8 away)
  • 0 views
  • 17 Nov, 2020
  • +30 other locations
Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2

The primary objectives of the study are: To describe the safety profile of different investigational vaccine regimens against herpes simplex virus type 2 (HSV-2). To evaluate the efficacy of the investigational vaccine regimens with respect to: the frequency of herpes simplex virus (HSV) deoxyribonucleic acid (DNA) detection in the genital …

sodium chloride
laboratory screening
western blot
recurrent genital herpes
vaccination
Investigational Site Number 8400010
 (9.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Baumann Cosmetic & Research Institute, Inc
 (9.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
A Study of AK104 a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

This is a Phase 2, global, multicenter, open label, single arm study designed to evaluate the efficacy, safety, tolerability, pharmacokinetic (PK), and immunogenicity of AK104 monotherapy in adult subjects with previously treated recurrent or metastatic cervical carcinoma.

corticosteroids
metastatic cervical cancer
immunosuppressive
adenosquamous cell carcinoma of the cervix
formalin-fixed paraffin-embedded
The Center for Gynecologic Oncology
 (6.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +19 other locations
PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

An Open-label study for patients who completed the previous studies, PTI-125-02 or PTI-125-03. Additional new patients will be included for a total of 100 patients enrolled for this study.

mini-mental state examination
positron emission tomography
rivastigmine
donepezil
dementia
Optimus U
 (9.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +8 other locations